Cahill Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Cahill Financial Advisors's PFE Position: Q1 2026 in Review
Cahill Financial Advisors reduced its Pfizer (PFE) stake by 0.68% in Q1 2026, selling an estimated $2.53K and leaving 13,788 shares worth $387K. The position accounts for 0.04% of the portfolio, ranked #206.
Cahill Financial Advisors first reported a position in PFE in Q3 2021 and has held it in 15 quarters since. The position peaked at $568K in Q3 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Cahill Financial Advisors held 13,788 shares of Pfizer worth $387K as of Q1 2026.
- Cahill Financial Advisors sold 95 Pfizer shares in Q1 2026, an estimated $2.53K.
- Pfizer made up 0.04% of Cahill Financial Advisors's portfolio in Q1 2026, its #206 holding.
- Cahill Financial Advisors first reported a position in Pfizer in Q3 2021 and has held it in 15 quarters since.
- Cahill Financial Advisors's Pfizer position peaked at $568K in Q3 2025.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Cahill Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.